Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-13 of 13

Sort by

Sort Order Select

Journal Articles

CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis

BA Pierson, JS Miller

Blood (1996) 88 (6): 2279–2287.

https://doi.org/10.1182/blood.V88.6.2279.bloodjournal8862279

Published: 1996

Journal Articles

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

CM Verfaillie, R Bhatia, W Miller, F Mortari, V Roy, S Burger, J McCullough, K Stieglbauer, G Dewald, S Heimfeld, JS Miller, PB McGlave

Blood (1996) 87 (11): 4770–4779.

https://doi.org/10.1182/blood.V87.11.4770.bloodjournal87114770

Published: 1996

Journal Articles

Malignant neoplasms following bone marrow transplantation

S Bhatia, NK Ramsay, M Steinbuch, KE Dusenbery, RS Shapiro, DJ Weisdorf, LL Robison, JS Miller, JP Neglia

Blood (1996) 87 (9): 3633–3639.

https://doi.org/10.1182/blood.V87.9.3633.bloodjournal8793633

Published: 1996

Journal Articles

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture

F Cervantes, BA Pierson, PB McGlave, CM Verfaillie, JS Miller

Blood (1996) 87 (6): 2476–2485.

https://doi.org/10.1182/blood.V87.6.2476.bloodjournal8762476

Published: 1996

Journal Articles

Human natural killer cell expansion is regulated by thrombospondin- mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors

BA Pierson, K Gupta, WS Hu, JS Miller

Blood (1996) 87 (1): 180–189.

https://doi.org/10.1182/blood.V87.1.180.180

Published: 1996

Journal Articles

A novel single-cell proliferation assay shows that long-term culture- initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC

CM Verfaillie, JS Miller

Blood (1995) 86 (6): 2137–2145.

https://doi.org/10.1182/blood.V86.6.2137.bloodjournal8662137

Published: 1995

Journal Articles

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony- stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte- CSF

DJ Weisdorf, CM Verfaillie, SM Davies, AH Filipovich, JE Jr Wagner, JS Miller, J Burroughs, NK Ramsay, JH Kersey, PB McGlave

Blood (1995) 85 (12): 3452–3456.

https://doi.org/10.1182/blood.V85.12.3452.bloodjournal85123452

Published: 1995

Journal Articles

CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells

CM Verfaillie, JS Miller

Blood (1994) 84 (5): 1442–1449.

https://doi.org/10.1182/blood.V84.5.1442.1442

Published: 1994

Journal Articles

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]

JS Miller, DC Arthur, CE Litz, JP Neglia, WJ Miller, DJ Weisdorf

Blood (1994) 83 (12): 3780–3786.

https://doi.org/10.1182/blood.V83.12.3780.3780

Published: 1994

Journal Articles

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor

JS Miller, KA Alley, P McGlave

Blood (1994) 83 (9): 2594–2601.

https://doi.org/10.1182/blood.V83.9.2594.2594

Published: 1994

Journal Articles

Role of monocytes in the expansion of human activated natural killer cells

JS Miller, S Oelkers, C Verfaillie, P McGlave

Blood (1992) 80 (9): 2221–2229.

https://doi.org/10.1182/blood.V80.9.2221.2221

Published: 1992

Journal Articles

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture

JS Miller, C Verfaillie, P McGlave

Blood (1992) 80 (9): 2182–2187.

https://doi.org/10.1182/blood.V80.9.2182.2182

Published: 1992

Journal Articles

Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors

JS Miller, C Verfaillie, P McGlave

Blood (1991) 77 (11): 2389–2395.

https://doi.org/10.1182/blood.V77.11.2389.2389

Published: 1991

Update search

NARROW

Publications

Format

Article Type

Date

Availability

CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

Malignant neoplasms following bone marrow transplantation

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture

Human natural killer cell expansion is regulated by thrombospondin- mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors

A novel single-cell proliferation assay shows that long-term culture- initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony- stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte- CSF

CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor

Role of monocytes in the expansion of human activated natural killer cells

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture

Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only